Lower numbers of circulating Natural Killer T (NK T) cells in individuals with human T lymphotropic virus type 1 (HTLV-1) associated neurological disease
- PMID: 19778295
- PMCID: PMC2792825
- DOI: 10.1111/j.1365-2249.2009.04019.x
Lower numbers of circulating Natural Killer T (NK T) cells in individuals with human T lymphotropic virus type 1 (HTLV-1) associated neurological disease
Abstract
Human T lymphotropic virus type 1 (HTLV-1) infects 10-20 million people worldwide. The majority of infected individuals are asymptomatic; however, approximately 3% develop the debilitating neurological disease HTLV-1-associated myelopathy/tropical spastic paraparesis (HAM/TSP). There is also currently no cure, vaccine or effective therapy for HTLV-1 infection, and the mechanisms for progression to HAM/TSP remain unclear. NK T cells are an immunoregulatory T cell subset whose frequencies and effector functions are associated critically with immunity against infectious diseases. We hypothesized that NK T cells are associated with HAM/TSP progression. We measured NK T cell frequencies and absolute numbers in individuals with HAM/TSP infection from two cohorts on two continents: São Paulo, Brazil and San Francisco, CA, USA, and found significantly lower levels when compared with healthy subjects and/or asymptomatic carriers. Also, the circulating NK T cell compartment in HAM/TSP subjects is comprised of significantly more CD4(+) and fewer CD8(+) cells than healthy controls. These findings suggest that lower numbers of circulating NK T cells and enrichment of the CD4(+) NK T subset are associated with HTLV-1 disease progression.
Figures



Similar articles
-
Low frequency of CD94/NKG2A+ T lymphocytes in patients with HTLV-1-associated myelopathy/tropical spastic paraparesis, but not in asymptomatic carriers.Blood. 2003 Jul 15;102(2):577-84. doi: 10.1182/blood-2002-09-2855. Epub 2003 Jan 30. Blood. 2003. PMID: 12560226
-
Human T cell lymphotropic virus type I (HTLV-I)-specific CD4+ T cells: immunodominance hierarchy and preferential infection with HTLV-I.J Immunol. 2004 Feb 1;172(3):1735-43. doi: 10.4049/jimmunol.172.3.1735. J Immunol. 2004. PMID: 14734756
-
Phenotypic study of peripheral blood leucocytes in HTLV-I-infected individuals from Minas Gerais, Brazil.Scand J Immunol. 2002 Jun;55(6):621-8. doi: 10.1046/j.1365-3083.2002.01087.x. Scand J Immunol. 2002. PMID: 12028566
-
HTLV-1-associated myelopathy/tropical spastic paraparesis (HAM/TSP) inflammatory network.Inflamm Allergy Drug Targets. 2008 Jun;7(2):98-107. doi: 10.2174/187152808785107642. Inflamm Allergy Drug Targets. 2008. PMID: 18691139 Review.
-
Human T-lymphotropic virus type 1 (HTLV-1) and cellular immune response in HTLV-1-associated myelopathy/tropical spastic paraparesis.J Neurovirol. 2020 Oct;26(5):652-663. doi: 10.1007/s13365-020-00881-w. Epub 2020 Jul 23. J Neurovirol. 2020. PMID: 32705480 Free PMC article. Review.
Cited by
-
Lower numbers of natural killer T cells in HIV-1 and Mycobacterium leprae co-infected patients.Immunology. 2012 May;136(1):96-102. doi: 10.1111/j.1365-2567.2012.03563.x. Immunology. 2012. PMID: 22269018 Free PMC article.
-
Clinical pathophysiology of human T-lymphotropic virus-type 1-associated myelopathy/tropical spastic paraparesis.Front Microbiol. 2012 Nov 9;3:389. doi: 10.3389/fmicb.2012.00389. eCollection 2012. Front Microbiol. 2012. PMID: 23162542 Free PMC article.
-
The Role of NK Cells in the Control of Viral Infection in HTLV-1 Carriers.J Immunol Res. 2019 Feb 28;2019:6574828. doi: 10.1155/2019/6574828. eCollection 2019. J Immunol Res. 2019. PMID: 30944834 Free PMC article.
-
Immunogenetics and the Pathological Mechanisms of Human T-Cell Leukemia VirusType 1- (HTLV-1-)Associated Myelopathy/Tropical Spastic Paraparesis (HAM/TSP).Interdiscip Perspect Infect Dis. 2010;2010:478461. doi: 10.1155/2010/478461. Epub 2010 Feb 10. Interdiscip Perspect Infect Dis. 2010. PMID: 20169122 Free PMC article.
-
Invariant Natural Killer T-cells and their subtypes may play a role in the pathogenesis of endometriosis.Clinics (Sao Paulo). 2022 May 13;77:100032. doi: 10.1016/j.clinsp.2022.100032. eCollection 2022. Clinics (Sao Paulo). 2022. PMID: 35576870 Free PMC article.
References
-
- Orland JR, Engstrom J, Fridey J, et al. Prevalence and clinical features of HTLV neurologic disease in the HTLV Outcomes study. Neurology. 2003;61:1588–94. - PubMed
-
- Osame M, Usuku K, Izumo S, et al. HTLV-I associated myelopathy, a new clinical entity. Lancet. 1986;1:1031–2. - PubMed
-
- Gessain A, Barin F, Vernant JC, et al. Antibodies to human T-lymphotropic virus type-I in patients with tropical spastic paraparesis. Lancet. 1985;2:407–10. - PubMed
-
- Itoyama Y, Minato S, Kira J, et al. Spontaneous proliferation of peripheral blood lymphocytes increased in patients with HTLV-I-associated myelopathy. Neurology. 1988;38:1302–7. - PubMed
-
- Bangham CR. Human T-cell leukaemia virus type I and neurological disease. Curr Opin Neurobiol. 1993;3:773–8. - PubMed
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Research Materials
Miscellaneous